- Bio-Engineering Department of Milan’s Don Gnocchi Foundation
- “Istituto Superiore di Sanità” of Rome
- Pharmacology Department of the University of Milan
- Italian State Research Center “CNR"
- European Brain Research Institute - Foundation “Rita Levi Montalcini” (Nobel Prize for Life Sciences)
Such experiments have largely demonstrated the added-values, both scientifically and industrially, of life-sciences & pharmaceutical research in weightlessness w.r.t. standard ground-based laboratories where gravity force the in-vitro cells to a behaviour completely different to the behaviour of in-vivo cell coltures.
A potentially huge advantage exists for those researchers and pharma-industries which might conceive a R&D and test plan in weightlessness, in terms of
- much higher fidelity for the planned R,D & Test activities
- much faster growth of coltures and samples (e.c. cells and bio-matter, crystals)
Such an industrial advantage is particularly evident for macromolecular compounds, vaccines and stem-cells-based therapies which on the ground are negatively influenced by the Earth’s gravity force
Unprecedented scenarios for the future of pharmacology opens up in weightlessness through the low-cost SpaceLand R,D&Test flight campaigns (60 days from contractual order to take-off & landing), in particular for
o tissue transplant
o therapies against cancer, brain degenerative syndroms (e.g. Alzheimer), osteoporosis and bone demineralization, neurovestibular pathologies, immune-system syndroms and pathologies
On board the SpaceLand flights even an 11-yr-old kid, a 93 yr-old man and a 100% disabled woman have operated as test subjects or test operators, proving the unprecedented user-friendliness of the SpaceLand training and flight operation system for research, development and qualification tests in weightlessness
